MetaCap

Polyrizon (PLRZ) vs Sensus Healthcare (SRTS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Polyrizon (PLRZ) has outperformed Sensus Healthcare (SRTS) over the past year, gaining 144.0% versus a loss of 43.8%. Sensus Healthcare is the larger company by market cap ($37.2 million vs $22.6 million), about 1.6 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PLRZ+143.97%SRTS-43.78%
+370%+153%-63%
Nov 21, 20251 yearNov 20, 2026
PLRZ-99.47%SRTS-65.60%
+74%-17%-108%
Oct 28, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PLRZ versus SRTS key metrics
MetricPLRZSRTS
Share price$9.31$2.26
Market cap$22.61M$37.20M
1-day change-8.42%-4.24%
YTD return+9.66%-43.22%
1-year return+143.97%-43.78%
5-year return—-63.55%
EPS (TTM)$-4.97$-0.97
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$27.48M
Revenue growth (YoY)—-34.26%
Net income (latest FY)$-3.33M$-7.72M
Gross margin—43.18%
Operating margin—-37.50%
Net margin—-28.09%
52-week high$18.20$5.49
52-week low$2.88$2.14
Distance from 52-week high-48.85%-58.83%
Analyst consensus—none
Avg. price target upside—+138.05%
Average volume38.21K208.74K
Shares outstanding2.43M16.46M
Employees260
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PLRZ has outperformed SRTS by 187.8 percentage points over the past year.

About Polyrizon

PLRZ stock →

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients.

Health Care · Medical/Dental Instruments · 2 employees

About Sensus Healthcare

SRTS stock →

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.

Health Care · Medical/Dental Instruments · 60 employees

PLRZ vs SRTS FAQ

Which is bigger, Polyrizon or Sensus Healthcare?

Sensus Healthcare (SRTS) is larger, with a market capitalization of $37.20M compared with $22.61M for Polyrizon (PLRZ).

Which stock has performed better over the past year, PLRZ or SRTS?

PLRZ returned +143.97% over the past 12 months, compared with -43.78% for SRTS (price return, excluding dividends). Past performance does not predict future results.

Are Polyrizon and Sensus Healthcare in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons